UBS Group »

Predictive Oncology shares owned by UBS Group

Quarter-by-quarter ownership of Predictive Oncology (POAI) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Predictive Oncology

Tip: Access up to 7 years of quarterly data

All positions including Predictive Oncology held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Predictive Oncology by UBS Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.2k 1.3k 2.55
2023-12-31 $8.4k 2.6k 3.29
2023-09-30 $7.9k 2.5k 3.20
2023-06-30 $19k 3.9k 4.86